What's Happening?
The global agriculture biotechnology market is projected to grow significantly, from USD 92.19 billion in 2025 to USD 144.25 billion by 2030, with a compound annual growth rate (CAGR) of 9.4%. North America is expected to dominate this market due to its robust research and development infrastructure, supportive regulations, and high adoption of genetically modified (GM) crops and bio-based inputs. The United States, supported by agencies like the USDA, EPA, and FDA, is at the forefront, with major companies such as Bayer Crop Science and Corteva Agriscience leading the charge. The animal biotechnology segment is anticipated to grow rapidly, driven by the demand for sustainable livestock systems and innovations in vaccines and genetic tools.
Why It's Important?
The expansion of the agriculture biotechnology market is crucial for addressing global food security challenges, especially as the population approaches 10 billion by 2050. Biotechnology offers solutions for producing more food with fewer resources and reduced environmental impact. The U.S. market's leadership in this sector underscores its strategic importance in global food production and sustainability efforts. The growth in animal biotechnology also highlights a shift towards healthier and more sustainable livestock practices, which could reduce antibiotic use and environmental impact.
What's Next?
As the market grows, further innovations in biotechnology are expected, particularly in CRISPR-based genome editing and microbial biofertilizers. These advancements will likely continue to transform agricultural practices, making them more sustainable and efficient. The U.S. will likely maintain its leadership role, influencing global standards and practices in agriculture biotechnology.
